ICHRAs and QSEHRAs present both challenges and opportunities for health plans. Given the potential advantages such ICHRAs could have for employers, the Departments of Labor, Health and Human Services, and Treasury estimated that by 2029 around 800,000 employers will offer ICHRAs and approximately 11.4 million individuals will receive ICHRAs. Understanding their impact on the I&SG market is crucial for actuaries to develop effective product strategies and pricing models in the evolving healthcare landscape.
This whitepaper discusses pricing implications of the rising popularity of Individual Coverage Health Reimbursement Arrangements (ICHRAs) and Qualified Small Employer Health Reimbursement Arrangements (QSEHRAs).
ICHRA/QSEHRA Consideration for Pricing Actuaries
